Michael Fleming1, Catherine A Fitton2, Markus F C Steiner2, James S McLay2, David Clark3, Albert King4, Robert S Lindsay5, Daniel F Mackay6, Jill P Pell6. 1. Institute of Health and Wellbeing, University of Glasgow, Glasgow, U.K. michael.fleming@glasgow.ac.uk. 2. Department of Child Health, University of Aberdeen, Aberdeen, U.K. 3. Information Services Division, Edinburgh, U.K. 4. ScotXed, Scottish Government, Edinburgh, U.K. 5. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K. 6. Institute of Health and Wellbeing, University of Glasgow, Glasgow, U.K.
Abstract
OBJECTIVE: This study was conducted to determine the association between childhood type 1 diabetes and educational and health outcomes. RESEARCH DESIGN AND METHODS: Record linkage of nine Scotland-wide databases (diabetes register, dispensed prescriptions, maternity records, hospital admissions, death certificates, annual pupil census, school absences/exclusions, school examinations, and unemployment) produced a cohort of 766,047 singleton children born in Scotland who attended Scottish schools between 2009 and 2013. We compared the health and education outcomes of schoolchildren receiving insulin with their peers, adjusting for potential confounders. RESULTS: The 3,330 children (0.47%) treated for type 1 diabetes were more likely to be admitted to the hospital (adjusted hazard ratio [HR] 3.97, 95% CI 3.79-4.16), die (adjusted HR 3.84, 95% CI 1.98-7.43), be absent from school (adjusted incidence rate ratio [IRR] 1.34, 95% CI 1.30-1.39), and have learning difficulties (adjusted odds ratio [OR] 1.19, 95% CI 1.03-1.38). Among children with type 1 diabetes, higher mean HbA1c (particularly HbA1c in the highest quintile) was associated with greater absenteeism (adjusted IRR 1.75, 95% CI 1.56-1.96), increased school exclusion (adjusted IRR 2.82, 95% CI 1.14-6.98), poorer attainment (adjusted OR 3.52, 95% CI 1.72-7.18), and higher risk of unemployment (adjusted OR 2.01, 95% CI 1.05-3.85). CONCLUSIONS: Children with type 1 diabetes fare worse than their peers in respect of education and health outcomes, especially if they have higher mean HbA1c. Interventions are required to minimize school absence and ensure that it does not affect educational attainment.
OBJECTIVE: This study was conducted to determine the association between childhood type 1 diabetes and educational and health outcomes. RESEARCH DESIGN AND METHODS: Record linkage of nine Scotland-wide databases (diabetes register, dispensed prescriptions, maternity records, hospital admissions, death certificates, annual pupil census, school absences/exclusions, school examinations, and unemployment) produced a cohort of 766,047 singleton children born in Scotland who attended Scottish schools between 2009 and 2013. We compared the health and education outcomes of schoolchildren receiving insulin with their peers, adjusting for potential confounders. RESULTS: The 3,330 children (0.47%) treated for type 1 diabetes were more likely to be admitted to the hospital (adjusted hazard ratio [HR] 3.97, 95% CI 3.79-4.16), die (adjusted HR 3.84, 95% CI 1.98-7.43), be absent from school (adjusted incidence rate ratio [IRR] 1.34, 95% CI 1.30-1.39), and have learning difficulties (adjusted odds ratio [OR] 1.19, 95% CI 1.03-1.38). Among children with type 1 diabetes, higher mean HbA1c (particularly HbA1c in the highest quintile) was associated with greater absenteeism (adjusted IRR 1.75, 95% CI 1.56-1.96), increased school exclusion (adjusted IRR 2.82, 95% CI 1.14-6.98), poorer attainment (adjusted OR 3.52, 95% CI 1.72-7.18), and higher risk of unemployment (adjusted OR 2.01, 95% CI 1.05-3.85). CONCLUSIONS:Children with type 1 diabetes fare worse than their peers in respect of education and health outcomes, especially if they have higher mean HbA1c. Interventions are required to minimize school absence and ensure that it does not affect educational attainment.
Authors: Ann Marie McCarthy; Scott Lindgren; Michelle A Mengeling; Eva Tsalikian; Janet C Engvall Journal: Pediatrics Date: 2002-01 Impact factor: 7.124
Authors: Dana C Perantie; Audrey Lim; Jenny Wu; Patrick Weaver; Stacie L Warren; Michelle Sadler; Neil H White; Tamara Hershey Journal: Pediatr Diabetes Date: 2008-01-12 Impact factor: 4.866
Authors: Ann Marie McCarthy; Scott Lindgren; Michelle A Mengeling; Eva Tsalikian; Janet Engvall Journal: Diabetes Care Date: 2003-01 Impact factor: 19.112
Authors: Michael Fleming; Catherine A Fitton; Markus F C Steiner; James S McLay; David Clark; Albert King; Daniel F Mackay; Jill P Pell Journal: Int J Epidemiol Date: 2020-08-01 Impact factor: 7.196
Authors: Justin A Indyk; Don Buckingham; Kathryn S Obrynba; Chris Servick; Kajal K Gandhi; Alyssa Kramer; Manmohan K Kamboj Journal: Pediatr Qual Saf Date: 2020-09-25
Authors: Christine A March; Lindsay Leikam; Linda M Siminerio; Elizabeth Miller; Ingrid M Libman Journal: J Pediatr Date: 2020-10-28 Impact factor: 4.406
Authors: Jamie Br Kidd; Alex D McMahon; Andrea Sherriff; Wendy Gnich; Ahmed Mahmoud; Lorna Md Macpherson; David I Conway Journal: BMJ Open Date: 2020-11-24 Impact factor: 2.692
Authors: Michael Fleming; Ehsan E Salim; Daniel F Mackay; Angela Henderson; Deborah Kinnear; David Clark; Albert King; James S McLay; Sally-Ann Cooper; Jill P Pell Journal: PLoS Med Date: 2020-10-13 Impact factor: 11.069
Authors: Esther Karen Pijl; Yvonne Theodora Maria Vanneste; Angelique Eveline de Rijk; Frans Joseph Maria Feron; Jolanda Mathijssen Journal: BMC Public Health Date: 2021-01-20 Impact factor: 3.295
Authors: Michael Fleming; James S McLay; David Clark; Albert King; Daniel F Mackay; Helen Minnis; Jill P Pell Journal: PLoS Med Date: 2021-11-12 Impact factor: 11.069